These data are corroborated by the observations that both membrane and soluble forms of interleukin-6 receptor (IL-6R) are upregulated at the blood serum level in colon cancer patients, and this increase correlates with the cancer size, suggesting a role for IL-6R in colorectal cancer progression. The gene discussed is IL6R; the disease is colonic neoplasm.